Skip to main content
. 2020 Jan 7;323(1):87–89. doi: 10.1001/jama.2019.17521

Figure 1. Overall Generic ARB Utilization Trends Between January 2018 and March 2019.

Figure 1.

The vertical lines indicate calendar dates of the first product recalls of valsartan, irbesartan, and losartan. Total numbers of prescriptions filled for all generic angiotensin receptor blockers (ARBs) every month are reported in the first row beneath the x-axis; percentages of total generic ARB use accounted for by each individual ARB are also shown.